Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.53%
SPX
+0.32%
IXIC
+0.25%
FTSE
-0.13%
N225
-0.04%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

Insmed's Strategic Advantage in AI-Driven Rare Disease Treatment Amid Market Volatility

4 days ago
publisher logo
Cashu

Insmed's Speculative Investment Challenges Amid Investor Caution and Financial Scrutiny

5 days ago
publisher logo
Cashu

Insmed's Mixed Analyst Opinions Highlight Strategic Challenges and Opportunities in Rare Disease Innovation

6 days ago

About

What does INSM do?
Insmed is a biopharmaceutical company based in Bridgewater, New Jersey, focusing on therapies for rare diseases, employing 912 staff. Its key products include ARIKAYCE, brensocatib, and TPIP for various lung diseases.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New Jersey, USA
Website
http://www.insmed.com
Stocks
Health Care
insm
Insmed
INSM
+1.70 (+1.65%)
104.57
USD
At close at Jul 16, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials

Key Stats

Market Cap
18.62B
Dividend Yield
0.00%
P/E Ratio
-18.38
EPS
-5.57
Revenue
363.71M
Avg. Volume
1.86M